Neurocrine Biosciences, Inc. (NBIX)
161.02
+0.16
(+0.10%)
USD |
NASDAQ |
Jun 11, 09:56
Neurocrine Biosciences EPS Diluted (TTM) : 6.504 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 6.504 |
| December 31, 2025 | 4.668 |
| September 30, 2025 | 4.187 |
| June 30, 2025 | 3.388 |
| March 31, 2025 | 2.949 |
| December 31, 2024 | 3.291 |
| September 30, 2024 | 3.733 |
| June 30, 2024 | 3.310 |
| March 31, 2024 | 3.638 |
| December 31, 2023 | 2.43 |
| September 30, 2023 | 1.869 |
| June 30, 2023 | 1.739 |
| March 31, 2023 | 0.6091 |
| December 31, 2022 | 1.540 |
| September 30, 2022 | 0.5806 |
| June 30, 2022 | 0.119 |
| March 31, 2022 | 0.7288 |
| December 31, 2021 | 0.9133 |
| September 30, 2021 | 4.569 |
| June 30, 2021 | 3.722 |
| March 31, 2021 | 4.099 |
| December 31, 2020 | 4.158 |
| September 30, 2020 | 0.9286 |
| June 30, 2020 | 2.106 |
| March 31, 2020 | 1.837 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.33 |
| September 30, 2019 | 0.1691 |
| June 30, 2019 | 0.1336 |
| March 31, 2019 | -0.4737 |
| December 31, 2018 | 0.1806 |
| September 30, 2018 | 0.0617 |
| June 30, 2018 | -0.5887 |
| March 31, 2018 | -1.203 |
| December 31, 2017 | -1.636 |
| September 30, 2017 | -2.216 |
| June 30, 2017 | -2.52 |
| March 31, 2017 | -2.30 |
| December 31, 2016 | -1.62 |
| September 30, 2016 | -1.45 |
| June 30, 2016 | -1.42 |
| March 31, 2016 | -1.24 |
| December 31, 2015 | -1.03 |
| September 30, 2015 | -0.95 |
| June 30, 2015 | -0.76 |
| March 31, 2015 | -0.66 |
| December 31, 2014 | -0.82 |
| September 30, 2014 | -0.72 |
| June 30, 2014 | -0.68 |
| March 31, 2014 | -0.68 |
| December 31, 2013 | -0.69 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Biogen, Inc. | 9.318 |
| Amgen, Inc. | 14.38 |
| Iovance Biotherapeutics, Inc. | -0.9501 |
| Voyager Therapeutics, Inc. | -1.978 |
| Incyte Corp. | 7.072 |